184 related articles for article (PubMed ID: 14520656)
1. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.
Klein M; Koedel U; Pfister HW; Kastenbauer S
Ann Neurol; 2003 Oct; 54(4):451-8. PubMed ID: 14520656
[TBL] [Abstract][Full Text] [Related]
2. Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment.
Klein M; Koedel U; Kastenbauer S; Pfister HW
Infection; 2008 Feb; 36(1):2-14. PubMed ID: 18084715
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis.
Worsøe L; Brandt CT; Lund SP; Ostergaard C; Thomsen J; Cayé-Thomasen P
Otol Neurotol; 2010 Apr; 31(3):394-403. PubMed ID: 20147868
[TBL] [Abstract][Full Text] [Related]
4. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis.
Worsøe L; Brandt CT; Lund SP; Østergaard C; Thomsen J; Cayé-Thomasen P
Laryngoscope; 2010 Sep; 120(9):1872-9. PubMed ID: 20717948
[TBL] [Abstract][Full Text] [Related]
5. MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis.
Klein M; Schmidt C; Kastenbauer S; Paul R; Kirschning CJ; Wagner H; Popp B; Pfister HW; Koedel U
J Infect Dis; 2007 Apr; 195(8):1189-93. PubMed ID: 17357057
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of post-meningitic cochlear injury with cerebrospinal fluid irrigation.
Yeung AH; Tinling SP; Brodie HA
Otolaryngol Head Neck Surg; 2006 Feb; 134(2):214-24. PubMed ID: 16455367
[TBL] [Abstract][Full Text] [Related]
7. Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis.
Demel C; Hoegen T; Giese A; Angele B; Pfister HW; Koedel U; Klein M
J Neuroinflammation; 2011 Jan; 8(1):7. PubMed ID: 21261959
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac.
Rappaport JM; Bhatt SM; Burkard RF; Merchant SN; Nadol JB
J Infect Dis; 1999 Jan; 179(1):264-8. PubMed ID: 9841852
[TBL] [Abstract][Full Text] [Related]
9. Time course of hearing loss in an animal model of pneumococcal meningitis.
Kesser BW; Hashisaki GT; Spindel JH; Ruth RA; Scheld WM
Otolaryngol Head Neck Surg; 1999 May; 120(5):628-37. PubMed ID: 10229585
[TBL] [Abstract][Full Text] [Related]
10. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol.
Peltola H; Roine I; Fernández J; González Mata A; Zavala I; Gonzalez Ayala S; Arbo A; Bologna R; Goyo J; López E; Miño G; Dourado de Andrade S; Sarna S; Jauhiainen T
Pediatrics; 2010 Jan; 125(1):e1-8. PubMed ID: 20008417
[TBL] [Abstract][Full Text] [Related]
11. Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis.
Muri L; Le ND; Zemp J; Grandgirard D; Leib SL
J Neuroinflammation; 2019 Jul; 16(1):156. PubMed ID: 31351490
[TBL] [Abstract][Full Text] [Related]
12. Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat.
Coimbra RS; Loquet G; Leib SL
Pediatr Res; 2007 Sep; 62(3):291-4. PubMed ID: 17622952
[TBL] [Abstract][Full Text] [Related]
13. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study.
Kim HH; Addison J; Suh E; Trune DR; Richter CP
Laryngoscope; 2007 Jul; 117(7):1209-15. PubMed ID: 17603319
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive N-acetyl-L-cysteine in treatment of murine pneumococcal meningitis.
Högen T; Demel C; Giese A; Angele B; Pfister HW; Koedel U; Klein M
Antimicrob Agents Chemother; 2013 Oct; 57(10):4825-30. PubMed ID: 23877681
[TBL] [Abstract][Full Text] [Related]
15. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes.
Brandt CT; Cayé-Thomasen P; Lund SP; Worsøe L; Ostergaard C; Frimodt-Møller N; Espersen F; Thomsen J; Lundgren JD
Neurobiol Dis; 2006 Aug; 23(2):300-11. PubMed ID: 16798006
[TBL] [Abstract][Full Text] [Related]
16. Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis.
Klein M; Koedel U; Pfister HW; Kastenbauer S
Brain Pathol; 2003 Apr; 13(2):123-32. PubMed ID: 12744466
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis.
Muri L; Grandgirard D; Buri M; Perny M; Leib SL
J Neuroinflammation; 2018 Aug; 15(1):233. PubMed ID: 30131074
[TBL] [Abstract][Full Text] [Related]
18. The Severity of Infection Determines the Localization of Damage and Extent of Sensorineural Hearing Loss in Experimental Pneumococcal Meningitis.
Perny M; Roccio M; Grandgirard D; Solyga M; Senn P; Leib SL
J Neurosci; 2016 Jul; 36(29):7740-9. PubMed ID: 27445150
[TBL] [Abstract][Full Text] [Related]
19. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy.
Kastenbauer S; Koedel U; Becker BF; Pfister HW
Eur J Pharmacol; 2002 Aug; 449(1-2):177-81. PubMed ID: 12163122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]